Specifically, PGRN expression by CD8+ T cells from peripheral blood mononuclear cells (PBMCs) was significantly higher in lung cancer patients compared to healthy individuals, whereas CCL3 levels were significantly reduced (Supplementary Fig. S6). This evidence concerns the gene CCL3 and lung cancer.